SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-118343
Filing Date
2020-10-27
Accepted
2020-10-27 06:04:13
Documents
18
Period of Report
2020-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2034306d1_8k.htm   iXBRL 8-K 29111
2 EXHIBIT 99.1 tm2034306d1_ex99-1.htm EX-99.1 20183
3 EXHIBIT 99.2 tm2034306d1_ex99-2.htm EX-99.2 21107
7 GRAPHIC ex99-2_logo.jpg GRAPHIC 2964
8 GRAPHIC image_001.jpg GRAPHIC 2653
9 GRAPHIC image_002.jpg GRAPHIC 3734
10 GRAPHIC image_003.jpg GRAPHIC 1839
  Complete submission text file 0001104659-20-118343.txt   275767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcli-20201022.xsd EX-101.SCH 3207
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20201022_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20201022_pre.xml EX-101.PRE 22724
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2034306d1_8k_htm.xml XML 3617
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 201261941
SIC: 2836 Biological Products, (No Diagnostic Substances)